Joseph K. Belanoff, Chief Executive Officer at CORCEPT THERAPEUTICS INC (CORT), sold 40,000 shares at $50.10 ($2.0M) on 2026-05-01, disclosed to the SEC on 2026-05-05.
Scheduled sale ($2.0M) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| CORT | SELL | 2025-12-03 | $3.2M | — | Filing → |
| CORT | SELL | 2025-11-05 | $4.9M | — | Filing → |
| CORT | SELL | 2025-10-03 | $6.8M | — | Filing → |